Affiliation:
1. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, 44801 Bochum, Germany
Abstract
Sepsis, a severe global healthcare challenge, is characterized by significant morbidity and mortality. The 2016 redefinition by the Third International Consensus Definitions Task Force emphasizes its complexity as a “life-threatening organ dysfunction caused by a dysregulated host response to infection”. Bacterial pathogens, historically dominant, exhibit geographic variations, influencing healthcare strategies. The intricate dynamics of bacterial immunity involve recognizing pathogen-associated molecular patterns, triggering innate immune responses and inflammatory cascades. Dysregulation leads to immunothrombosis, disseminated intravascular coagulation, and mitochondrial dysfunction, contributing to the septic state. Viral sepsis, historically less prevalent, saw a paradigm shift during the COVID-19 pandemic, underscoring the need to understand the immunological response. Retinoic acid-inducible gene I-like receptors and Toll-like receptors play pivotal roles, and the cytokine storm in COVID-19 differs from bacterial sepsis. Latent viruses like human cytomegalovirus impact sepsis by reactivating during the immunosuppressive phases. Challenges in sepsis management include rapid pathogen identification, antibiotic resistance monitoring, and balancing therapy beyond antibiotics. This review highlights the evolving sepsis landscape, emphasizing the need for pathogen-specific therapeutic developments in a dynamic and heterogeneous clinical setting.
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference64 articles.
1. Inzidenz der Sepsis in Deutschland und weltweit: Aktueller Wissensstand und Limitationen der Erhebung in Abrechnungsdaten;Schwarzkopf;Med. Klin. Intensivmed. Notfmed.,2022
2. Rahmel, T., Schmitz, S., Nowak, H., Schepanek, K., Bergmann, L., Halberstadt, P., Horter, S., Peters, J., and Adamzik, M. (2020). Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare. PLoS ONE, 15.
3. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation;Campion;J. Intensive Care Med.,2018
4. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis;Seymour;JAMA,2019
5. Sepsis mortality score for the prediction of mortality in septic patients;Shukeri;J. Crit. Care,2018